Andrew Kirby
Papers
1
Total Citations
29
H-Index
1
About
Andrew Kirby is a leading colorectal surgeon and clinical researcher whose work centres on improving surgical outcomes in rectal cancer, with a particular focus on preventing anastomotic leaks—a devastating complication that occurs in up to 20% of patients. His landmark contribution is the IntAct trial, an unblinded randomised controlled trial investigating intraoperative fluorescence angiography with indocyanine green (ICG) to assess bowel perfusion during surgery. This study, published in 2025 and already garnering 29 citations, provides critical evidence on whether real-time vascular imaging can safely reduce leak rates, addressing a long-standing controversy in the field. Kirby’s research bridges the gap between innovative imaging technology and practical surgical decision-making, offering a potential new standard of care. Beyond this trial, his work has influenced perioperative protocols and patient safety guidelines. With a career dedicated to high-impact, practice-changing studies, Kirby is recognised as a key voice in evidence-based colorectal surgery, and his findings continue to shape how surgeons approach complex pelvic resections.
Research Focus
Key Achievements
Top Papers
- 1